NEGR1 and depressive symptom measurement: NEGR1 is associated with several human pathologies, including cancer, obesity, diabetes, neurodevelopmental disorders, depression, and ASD (Kim et al., 2014; Szczurkowska et al., 2018; Noh et al., 2020).